Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04132232 · ClinicalTrials.gov registry record · NA
Smoking Reduction In Gravid Substance Use Disorders
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT04132232 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 74 participants.
The verdict
NCT04132232, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The aim of this study is to encourage smoking cessation in women with substance use disorders by providing knowledge of expired carbon monoxide. We hypothesize that women who are provided knowledge of their expired carbon monoxide and the associated percent fetal carboxyhemoglobin will have a greater success at quitting smoking during pregnancy than women who are not provided this information. A secondary aim of the study is to correlate expired carbon monoxide throughout pregnancy with infant birth weight.
Interventions
- DIAGNOSTIC_TEST knowledge of expired maternal carbon monoxide and fetal carboxyhemoglobin levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04132232
The ClinicalTrials.gov registry entry for NCT04132232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which knowledge of expired maternal carbon monoxide and fetal carboxyhemoglobin levels is the first listed.
NCT04132232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04132232 about?
NCT04132232 is a clinical study titled "Smoking Reduction In Gravid Substance Use Disorders". The aim of this study is to encourage smoking cessation in women with substance use disorders by providing knowledge of expired carbon monoxide. We hypothesize that women who are provided knowledge of their expired carbon monoxide and the associated percent fetal carboxyhemoglobin will have a greate...
What is the current status of trial NCT04132232?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2021-02-15. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT04132232?
The interventions under investigation include: knowledge of expired maternal carbon monoxide and fetal carboxyhemoglobin levels (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04132232?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.